Search General Info
Search Education
Search Partnering Companies
photo
Speaker

Matthew Hudes

CEO, BDLBIOLOGX
Vancouver, Washington, United States
Matthew Hudes is the Founder and CEO of bdlBiologx, a company devoted to helping the products of innovative companies reach patients more quickly. bdlBiologx provides 1) on-demand services to achieve company growth 2) leading-edge Business Development and Licensing (BDL) processes and systems, and 3) capability-building to support the growth of a BDL function within a company.
For the prior 11 years, Matthew was the BioPharma practice leader for Deloitte. In this role, he provided guidance and direction to clients and to the firm’s Audit, Tax, Consulting, and Advisory Services practices. Deloitte is recognized as the leading full-scope professional services firm in Life Sciences.
During the course of his long career, Matthew has provided strategic professional services to leading Biotechnology, Pharmaceutical, and Medical Technology companies, as well as Academic Research Centers and regional centers for Life Sciences. He has worked with leading Life Sciences innovation centers in the U.S. and globally.
He speaks frequently about such topics as digital health, fostering innovation, personalized medicine, the use of technology for innovating clinical research, finance transformation, manufacturing and quality, regulatory compliance, and supply chain. He was a member of the Board of Directors of BIOCOM, a faculty member and executive sponsor of the UC Berkeley BioExec Institute, a member of the Board of Directors of the Bay Area BioEconomy Initiative, and he was the executive sponsor of Deloitte’s unique innovation collaboration with the University of California.
Previously, he was the Chairman and CEO of Accélère, a software company that developed a system to find patients (and investigators) for clinical trials and to improve researchers’ access to information typically “trapped” in laboratory and medical systems.
Formerly, Matthew led the global Capgemini Life Sciences Biotechnology and R&D practice. As a former Partner with Ernst & Young LLP, he founded the firm’s Life Sciences Consulting practice and led the firm’s Biotechnology Consulting practice. He served as a strategic advisor to leading-edge companies in Life Sciences and Technology over a period of more than 17 years.
Matthew received an MBA from Santa Clara University and a BA from the University of Connecticut.
Speaking In
4:00 PM - 4:45 PM (EDT)
Tuesday, June 15